← Eichor
Condition: Coagulation Factor Deficiency Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Coagulation Factor Deficiency

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

A Clinical Study to Assess Sutacimig in Participants With Congenital Factor VII Deficiency
Phase 2 · 1 location(s) · Hemab ApS · NCT07347249SWIFT - SWIss Factor XIII Trial in PPH
Phase 4 · 9 location(s) · Christian Haslinger · NCT06481995Embolization in Hereditary Coagulopathies
NA · 1 location(s) · University of Sao Paulo General Hospital · NCT05629130A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Hea
Phase 1 · 10 location(s) · Equilibra Bioscience LLC · NCT06349473Longitudinal Cohort of Thrombosis and Hemostasis Diseases
Phase N/A · 5 location(s) · Peking University People's Hospital · NCT06727669Long-term Anticoagulation in a Patient With Severe Hemophilia A
Phase N/A · 1 location(s) · University Hospital, Strasbourg, France · NCT07314983The European Paediatric Network for Haemophilia Management ( PedNet Registry)
Phase N/A · 39 location(s) · PedNet Haemophilia Research Foundation · NCT02979119A Study to Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan
Phase N/A · 10 location(s) · Sanofi · NCT06684314Point of Care Fibrinogen Measurement in Trauma Patients in the Emergency Department
Phase N/A · 1 location(s) · Erasmus Medical Center · NCT07097337Efficacy and Safety of 4F-PCC (4-Factor Prothrombin Complex Concentrate) in Adult Patients Undergoing Complex Cardiovasc
Phase 3 · 18 location(s) · CSL Behring · NCT07094087Efanesoctocog Alfa Prophylaxis in Patients With Hemophilia A With Synovial Hypertrophy
Phase 4 · 13 location(s) · Sanofi · NCT06941870Long-term Study Evaluating Joint Health in People With Haemophilia A Receiving Real-world Prophylactic Treatment With Ef
Phase 4 · 29 location(s) · Swedish Orphan Biovitrum · NCT06940830Hemlibra in Mild Hemophilia A
Phase 4 · 1 location(s) · Indiana Hemophilia &Thrombosis Center, Inc. · NCT04567511Hemophilia A Research Program
Phase N/A · 1 location(s) · University of Washington · NCT07414511Phase 3 Study of Fibrinogen Concentrate (CSL511) in Subjects With Pseudomyxoma Peritonei Undergoing Cytoreductive Surger
Phase 3 · 1 location(s) · CSL Behring · NCT06617897ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Phase N/A · 71 location(s) · American Thrombosis and Hemostasis Network · NCT04398628External Multicenter Validation of the APTTO Model for Prolonged APTT Using Clot Waveform Analysis
Phase N/A · 16 location(s) · Instituto de Investigación Sanitaria de la Fundación Jiménez · NCT07418099An Open-label, Multicenter Phase I/II Clinical Trial to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic
Phase 1/Phase 2 · 9 location(s) · Shanghai RAAS Blood Products Co., Ltd. · NCT07644832Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Antico
Phase N/A · 1 location(s) · Octapharma · NCT06429787
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.